Mounjaro (tirzepatide) is a once-weekly injectable prescription drug that is approved by the Food and Drug Administration (FDA) for use in adults with Type 2 diabetes
The key is working with your provider to find the dose that balances results with tolerability, and knowing exactly how many units that dose translates to for your specific concentration
received research support from Cerenovus Inc, Medtronic, Endovascular Engineering, Frontier Bio, Sensome Inc, Endomimetics, Ancure LLC, Neurogami Medical, MIVI Biosciences, Monarch Biosciences, Stryker, Conway Medical, Piraeus Medical, Rion Inc, and Bionaut Labs
In order to purchase with Above Wellness, we require a health history questionnaire to confirm elgibility